Categories: AnalyticsArtificial IntelligenceDataDrugITPlatform
We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.06.2025 | Seed | $2.45M | - |
Mentions in press and media 5
| Date | Title | Description |
| 25.06.2025 | OutSee Secures £1.8M Seed Funding to Revolutionize Drug Discovery | In the world of genomics and drug discovery, innovation is the lifeblood. OutSee, a Cambridge-based company, has just injected new energy into this field by securing £1.8 million in seed funding. This financial boost, led by Ahren Innovatio... |
| 24.06.2025 | OutSee raises £1.8M to expand therapeutic pipeline using predictive genomics | Cambridge-based OutSee has secured £1.8 million in seed funding. The company has previously received over £500,000 in precision medicine grants from Innovate UK to support technology extensions and to test their application on dementia case... |
| 24.06.2025 | OutSee Raises £1.8M in Seed Funding | OutSee, a Cambridge, UK-based genomics and drug discovery company, raised £1.8M in Seed funding.
The round wads led by Ahren Innovation Capital and with investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.
The company in... |
| 24.06.2025 | OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics | Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures
Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and pro... |
| - | OutSee | “We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...” |
Reviews 0
